Gilead Sciences, Inc.

NasdaqGS:GILD Stock Report

Market Cap: US$113.5b

Gilead Sciences Future Growth

Future criteria checks 4/6

Gilead Sciences is forecast to grow earnings and revenue by 40.7% and 2.5% per annum respectively. EPS is expected to grow by 42.6% per annum. Return on equity is forecast to be 38.6% in 3 years.

Key information

40.7%

Earnings growth rate

42.6%

EPS growth rate

Biotechs earnings growth27.5%
Revenue growth rate2.5%
Future return on equity38.6%
Analyst coverage

Good

Last updated17 Dec 2024

Recent future growth updates

Recent updates

Gilead: A Large-Cap Pharma With Limited Patent Cliff Exposure

Dec 18

Gilead Sciences, Inc.'s (NASDAQ:GILD) Business And Shares Still Trailing The Industry

Dec 13
Gilead Sciences, Inc.'s (NASDAQ:GILD) Business And Shares Still Trailing The Industry

We Think You Can Look Beyond Gilead Sciences' (NASDAQ:GILD) Lackluster Earnings

Nov 13
We Think You Can Look Beyond Gilead Sciences' (NASDAQ:GILD) Lackluster Earnings

Why Gilead's Solid Q3 Earnings Could Point To A Dividend Surprise Next Year

Nov 07

Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It

Oct 01

Gilead Sciences: Buy This Bargain Before It's Gone

Aug 30

Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?

Aug 05

A Look At Gilead Sciences After Its Recent Weakness

Jul 27

Gilead Records Positive Phase III Results In HIV

Jun 22

Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Jun 13
Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?

Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors

May 23

We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation

Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Apr 22
Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark

Gilead Sciences: Some Signs Of An Impending Bottom

Apr 22

Earnings and Revenue Growth Forecasts

NasdaqGS:GILD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202629,2637,52210,90810,21925
12/31/202528,4116,93310,58710,15628
12/31/202428,3042628,1386,71128
9/30/202428,2991269,43110,022N/A
6/30/202427,8051,0546,8967,468N/A
3/31/202427,4504857,9008,481N/A
12/31/202327,1165,6657,4218,006N/A
9/30/202327,3915,8767,8538,404N/A
6/30/202327,3825,4848,9269,512N/A
3/31/202327,0435,5838,3868,976N/A
12/31/202227,2814,5928,3449,072N/A
9/30/202227,1363,3349,0079,710N/A
6/30/202227,5154,1379,41510,100N/A
3/31/202227,4724,5159,95310,614N/A
12/31/202127,3056,22510,80511,384N/A
9/30/202127,4827,3949,49110,095N/A
6/30/202126,6385,1628,4729,092N/A
3/31/202125,5643018,6989,342N/A
12/31/202024,6891237,5188,168N/A
9/30/202023,1471,2688,1608,832N/A
6/30/202022,174-2578,5109,227N/A
3/31/202022,7164,9628,2449,003N/A
12/31/201922,4495,3868,3199,144N/A
9/30/201922,3652,6938,0398,909N/A
6/30/201922,3575,9557,6398,476N/A
3/31/201922,3205,8926,7587,707N/A
12/31/201822,1275,4557,4768,400N/A
9/30/201822,2811,5877,9128,808N/A
6/30/201823,1972,208N/A9,290N/A
3/31/201824,6903,464N/A11,243N/A
12/31/201726,1074,628N/A11,898N/A
9/30/201727,47811,601N/A12,684N/A
6/30/201728,46612,213N/A14,383N/A
3/31/201729,10112,637N/A15,842N/A
12/31/201630,39013,501N/A17,047N/A
9/30/201631,57615,076N/A18,382N/A
6/30/201632,37116,346N/A18,085N/A
3/31/201632,83917,341N/A18,758N/A
12/31/201532,63918,108N/A21,250N/A
9/30/201531,44716,912N/A18,476N/A
6/30/201529,19415,043N/A18,424N/A
3/31/201527,48514,207N/A16,951N/A
12/31/201424,89012,101N/A12,818N/A
9/30/201420,6969,406N/A10,524N/A
6/30/201417,4377,463N/A7,233N/A
3/31/201413,6694,580N/A4,001N/A
12/31/201311,2023,075N/A3,105N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GILD's forecast earnings growth (40.7% per year) is above the savings rate (2.6%).

Earnings vs Market: GILD's earnings (40.7% per year) are forecast to grow faster than the US market (15.2% per year).

High Growth Earnings: GILD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GILD's revenue (2.5% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: GILD's revenue (2.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: GILD's Return on Equity is forecast to be high in 3 years time (38.6%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gilead Sciences, Inc. is covered by 75 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Brian SkorneyBaird
Ishan MajumdarBaptista Research